SynthesisBMC cancer2025

Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis.

Xin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.